Covid-19 roundup: EMA begins rolling review of first Chinese vaccine; After 100% efficacy trial, teenagers could be eligible for Pfizer’s vaccine next week

Sinovac’s shot — which was just effective enough to meet regulatory standards — is now the first Chinese Covid-19 vaccine to be considered by the European Medicines Agency.

The EMA’s human medicines committee (CHMP) said on Tuesday that it’s kicking off a rolling review of the inactivated vaccine, dubbed CoronaVac...

Click to view original post